These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23700488)

  • 1. Ageing Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASH.
    Bjursell M; Wedin M; Admyre T; Hermansson M; Böttcher G; Göransson M; Lindén D; Bamberg K; Oscarsson J; Bohlooly-Y M
    PLoS One; 2013; 8(5):e64721. PubMed ID: 23700488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.
    Duparc T; Plovier H; Marrachelli VG; Van Hul M; Essaghir A; Ståhlman M; Matamoros S; Geurts L; Pardo-Tendero MM; Druart C; Delzenne NM; Demoulin JB; van der Merwe SW; van Pelt J; Bäckhed F; Monleon D; Everard A; Cani PD
    Gut; 2017 Apr; 66(4):620-632. PubMed ID: 27196572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice.
    Wu WB; Chen YY; Zhu B; Peng XM; Zhang SW; Zhou ML
    Biochimie; 2015 Aug; 115():86-92. PubMed ID: 26025474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice.
    Kim KH; Choi S; Zhou Y; Kim EY; Lee JM; Saha PK; Anakk S; Moore DD
    Hepatology; 2017 Aug; 66(2):498-509. PubMed ID: 28378930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota-induced obesity requires farnesoid X receptor.
    Parséus A; Sommer N; Sommer F; Caesar R; Molinaro A; Ståhlman M; Greiner TU; Perkins R; Bäckhed F
    Gut; 2017 Mar; 66(3):429-437. PubMed ID: 26740296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.
    Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y
    Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet.
    Kong B; Luyendyk JP; Tawfik O; Guo GL
    J Pharmacol Exp Ther; 2009 Jan; 328(1):116-22. PubMed ID: 18948497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet.
    Bjursell M; Admyre T; Göransson M; Marley AE; Smith DM; Oscarsson J; Bohlooly-Y M
    Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E211-20. PubMed ID: 20959533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ob mice.
    Zhang Y; Ge X; Heemstra LA; Chen WD; Xu J; Smith JL; Ma H; Kasim N; Edwards PA; Novak CM
    Mol Endocrinol; 2012 Feb; 26(2):272-80. PubMed ID: 22261820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis.
    Wu W; Liu X; Peng X; Xue R; Ji L; Shen X; Chen S; Gu J; Zhang S
    Biochem Biophys Res Commun; 2014 May; 448(1):50-5. PubMed ID: 24747563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids as regulators of hepatic lipid and glucose metabolism.
    Trauner M; Claudel T; Fickert P; Moustafa T; Wagner M
    Dig Dis; 2010; 28(1):220-4. PubMed ID: 20460915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4.
    Deng W; Fan W; Tang T; Wan H; Zhao S; Tan Y; Oware KA; Tan J; Li J; Qu S
    Oxid Med Cell Longev; 2022; 2022():3589525. PubMed ID: 35251469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance.
    Ma Y; Huang Y; Yan L; Gao M; Liu D
    Pharm Res; 2013 May; 30(5):1447-57. PubMed ID: 23371517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
    Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
    J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium cholate ameliorates nonalcoholic steatohepatitis by activation of FXR signaling.
    Pan L; Yu Z; Liang X; Yao J; Fu Y; He X; Ren X; Chen J; Li X; Lu M; Lan T
    Hepatol Commun; 2023 Feb; 7(2):e0039. PubMed ID: 36706173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte glutathione peroxidase-1 deficiency improves hepatic glucose metabolism and decreases steatohepatitis in mice.
    Merry TL; Tran M; Dodd GT; Mangiafico SP; Wiede F; Kaur S; McLean CL; Andrikopoulos S; Tiganis T
    Diabetologia; 2016 Dec; 59(12):2632-2644. PubMed ID: 27628106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation.
    Sheng L; Jena PK; Liu HX; Kalanetra KM; Gonzalez FJ; French SW; Krishnan VV; Mills DA; Wan YY
    Sci Rep; 2017 May; 7(1):1748. PubMed ID: 28496104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
    Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
    Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatoprotective effect of Typhaneoside on non-alcoholic fatty liver disease via farnesoid X receptor in vivo and in vitro.
    Zheng Y; Zhao J; Miao D; Xu T; Wang L; Liu C; Gao Y; Yu L; Shen C
    Biomed Pharmacother; 2023 Aug; 164():114957. PubMed ID: 37295248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation.
    Carino A; Marchianò S; Biagioli M; Fiorucci C; Zampella A; Monti MC; Morretta E; Bordoni M; Di Giorgio C; Roselli R; Ricci P; Distrutti E; Fiorucci S
    Nutrients; 2019 May; 11(5):. PubMed ID: 31117231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.